Detalhe da pesquisa
1.
The genetics of nodal marginal zone lymphoma.
Blood
; 128(10): 1362-73, 2016 09 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27335277
2.
Clinical, pathological, and biological characterization of Richter syndrome developing after ibrutinib treatment for relapsed chronic lymphocytic leukemia.
Hematol Oncol
; 2018 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-29484684
3.
Decreased function of Fas and variations of the perforin gene in adult patients with primary immune thrombocytopenia.
Br J Haematol
; 176(2): 258-267, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27391055
4.
Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia.
Blood
; 126(16): 1921-4, 2015 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26276669
5.
Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia.
Blood
; 119(2): 521-9, 2012 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-22077063
6.
Progressive telomere shortening is part of the natural history of chronic lymphocytic leukaemia and impacts clinical outcome: evidences from long term follow-up.
Br J Haematol
; 181(5): 693-695, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28369711
7.
Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphoma.
Blood
; 118(18): 4930-4, 2011 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-21881048
8.
Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness.
Blood
; 118(26): 6904-8, 2011 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-22039264
9.
Mutational status of IGHV is the most reliable prognostic marker in trisomy 12 chronic lymphocytic leukemia.
Haematologica
; 102(11): e443-e446, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28751560
10.
The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas.
Blood
; 113(20): 4918-21, 2009 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-19258598
11.
Clinical impact of small subclones harboring NOTCH1, SF3B1 or BIRC3 mutations in chronic lymphocytic leukemia.
Haematologica
; 101(4): e135-8, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26819056
12.
Genomic profiling of Richter's syndrome: recurrent lesions and differences with de novo diffuse large B-cell lymphomas.
Hematol Oncol
; 28(2): 62-7, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20014148
13.
Molecular characterization of post-transplant lymphoproliferative disorders of donor origin occurring in liver transplant recipients.
J Pathol
; 218(4): 478-86, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19391128
14.
The prognostic value of TP53 mutations in chronic lymphocytic leukemia is independent of Del17p13: implications for overall survival and chemorefractoriness.
Clin Cancer Res
; 15(3): 995-1004, 2009 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19188171
15.
Epigenetic inactivation of suppressors of cytokine signalling in Philadelphia-negative chronic myeloproliferative disorders.
Br J Haematol
; 141(4): 504-11, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18318760
16.
Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome.
Br J Haematol
; 142(2): 202-15, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18492108
17.
Molecular analysis of immunoglobulin variable genes in human immunodeficiency virus-related non-Hodgkin's lymphoma reveals implications for disease pathogenesis and histogenesis.
Haematologica
; 93(8): 1178-85, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18556404
18.
CD49d expression is an independent risk factor of progressive disease in early stage chronic lymphocytic leukemia.
Haematologica
; 93(10): 1575-9, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18641015
19.
Usefulness of JAK2V617F mutation in distinguishing idiopathic erythrocytosis from polycythemia vera.
Leuk Res
; 31(1): 97-101, 2007 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-16620973
20.
Hairy cell leukaemia complicated by anti-MAG paraproteinemic demyelinating neuropathy: resolution of neurological syndrome after cladribrine treatment.
Leuk Res
; 31(6): 873-6, 2007 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-17007925